Northstar Neuroscience investor sells 2.54 million remaining shares

By Lisa Kerner

Charlotte, N.C., April 20 - Investors led by RA Capital Management, LLC reported the sale of their remaining 2,539,139 shares of Northstar Neuroscience, Inc. between Feb. 2 and April 14 in a schedule 13D/A filed with the Securities and Exchange Commission on Monday.

The shares were priced at $1.90 to $1.93 each, the filing said.

RA Capital no longer has a stake in the Seattle-based medical device company.

In January, Northstar announced its board of directors approved a plan of complete liquidation and dissolution of the company following a review of strategic alternatives.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.